Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Acute Decompensated Heart Failure: full-pipeline trial registry

4 of 13 indexed Acute Decompensated Heart Failure trials are currently recruiting.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 4 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Acute Decompensated Heart Failure: 13 US clinical trials tracked, 4 recruiting.

Acute Decompensated Heart Failure is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Reprieve Cardiovascular, running 2 of these trials.

Enrollment posture brief

Registry condition acute-decompensated-heart-failure

OPEN 4 | RECR 31% | LATE 2 | EARLY 2 | RANK #1315 | SPON 2

Nearest open-share peer: Adolescent Obesity (31% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Acute Decompensated Hear (th…31%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Acute Decompensated Heart Failure

Acute Decompensated Heart Failure lists 4 open slots (31% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Decompensated Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Decompensated Heart Failure is recruiting below its size-band peers.

    4 of 13 indexed trials (30.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Acute Decompensated Heart Failure research.

    Reprieve Cardiovascular accounts for 2 of 13 trials (15.4%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Decompensated Heart Failure enrolment sits around 100 participants.

    Median target enrolment is 100 among the 13 trials that report a genuine target (sentinel values excluded). 5 of those (38.5%) plan for fewer than 100 participants.

  4. Acute Decompensated Heart Failure research is mostly interventional.

    10 interventional and 3 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32

Open and recent trials

13 total, page 1 of 1

RECRUITING 500 participants

Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

UConn Health

NCT00762008

RECRUITING Phase 3 400 participants

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Reprieve Cardiovascular

NCT06898515

RECRUITING NA 100 participants

Low Level Tragus Stimulation in Acute Decompensated Heart Failure

University of Oklahoma

NCT02898181

RECRUITING 50 participants

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

NYU Langone Health

NCT05240651

ACTIVE NOT RECRUITING NA 30 participants

DORAYA-HF Early Feasibility Study

Revamp Medical

NCT05206422

ACTIVE NOT RECRUITING Phase 1 10 participants

IC14 for Treatment of Acute Decompensated Heart Failure

Implicit Bioscience

NCT06556810

ACTIVE NOT RECRUITING NA 10 participants

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Abiomed

NCT05291884

COMPLETED Phase 3 2,157 participants

Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

Cardiorentis

NCT01661634

COMPLETED 930 participants

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

Alere San Diego

NCT01291836

COMPLETED Phase 2 620 participants

A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure

Trevena

NCT01966601

COMPLETED NA 600 participants

Evaluation of Cardiopulmonary Diseases by Ultrasound

Echosense

NCT02248831

COMPLETED NA 100 participants

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

Reprieve Cardiovascular

NCT05174312

COMPLETED NA 1 participants

RAAS Optimization for Acute CHF Patients

University of Florida

NCT03695120

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2

Top Sponsors

Echosense 1 trials
Alere San Diego 1 trials
Cardiorentis 1 trials
Trevena 1 trials
Revamp Medical 1 trials
Abiomed 1 trials
UConn Health 1 trials

Named interventions

Most-linked intervention names on Acute Decompensated Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
TRV027 Dose #3 Drug
1 trials
TRV027 Dose #2 Drug
1 trials
TRV027 Dose #1 Drug
1 trials
Recording Doppler ultrasound signals noninvasively Device
1 trials
Ularitide Drug
1 trials
Diuretic Drug
1 trials
Reprieve Decongestion Management System Device
1 trials

US sites by state

Facility locations filed on Acute Decompensated Heart Failure trials. A trial with sites in several states counts in each.

Michigan 5 trials
California 5 trials
Ohio 4 trials
Missouri 4 trials
Georgia 4 trials
Florida 4 trials
Texas 3 trials
New York 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Decompensated Heart Failure page

13 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Acute Decompensated Heart Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Reprieve Cardiovascular sponsors the most Acute Decompensated Heart Failure trials on record, review their full trial history before evaluating a specific study. See Reprieve Cardiovascular's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Decompensated Heart Failure condition card totals 13 registered trials; most-linked intervention Placebo; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.